- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 126,930 | 10.07.24 21:50:00 | +0,890 | +0,71% | 126,910 | 126,930 | 125,240 | 126,040 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 96,520 | 10.07.24 21:49:42 | +4,810 | +5,24% | 96,230 | 96,600 | 92,000 | 91,710 |
